Survivor Views Press Releases
Cancer patients and survivors continue to deal with the negative effects of the coronavirus pandemic on their ability to access necessary health care.
According to an article published this week in JAMA Oncology, nearly 1 in 5 cancer patients surveyed said the pandemic would make them less likely to enroll in a trial. The top reason given for not enrolling is fear of COVID-19 exposure.
Cancer patients and survivors continue to experience potentially serious coronavirus-related health care delays and high levels of anxiety associated with the ongoing pandemic.
Cancer patients and survivors are finding it increasingly challenging to get necessary health care as the COVID-19 pandemic persists. Many are experiencing financial stress and mental health issues as they try to navigate the difficult health and economic environment.
Cancer patients and those who’ve recently completed treatment are finding it challenging to get necessary health care in the midst of the COVID-19 pandemic and many are experiencing financial stress trying to afford care in an increasingly difficult economic environment.
Some recent and current cancer patients are making changes to their cancer treatment due to the coverage and cost of prescription drugs and surprise medical bills, according to new survey results from the American Cancer Society Cancer Action Network (ACS CAN).
Washington, D.C. – Barriers to accessing appropriate therapies to address the physical and psychological side effects of cancer treatment continue to persist for patients and survivors, according to survey results from the American Cancer Society Cancer Action Network (ACS CAN).
Washington, D.C. – The American Cancer Society Cancer Action Network (ACS CAN) is launching a new initiative this week that will promote the experiences of cancer survivors in cancer-related policymaking.
A new nationwide survey of cancer patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage policy go into effect.